Similar Articles
441 Is every microorganism detected in the intensive care unit a nosocomial infection? Isn’t prevention more important than detection?
442 Differences of core genes in liver fibrosis and hepatocellular carcinoma: Evidence from integrated bioinformatics and immunohistochemical analysis
443 Difference in incidence of developing hepatocellular carcinoma between hepatitis B virus-and hepatitis C virus-infected patients
444 Radiomic analysis based on multi-phase magnetic resonance imaging to predict preoperatively microvascular invasion in hepatocellular carcinoma
445 Second-line treatment of advanced hepatocellular carcinoma: Time for more individualized treatment options?
446 Impact of alcohol consumption on treatment outcome of hepatocellular carcinoma patients with viral hepatitis who underwent transarterial chemoembolization
447 DNA and RNA oxidative damage in hepatocellular carcinoma patients and mortality during the first year of liver transplantation
448 Direct-acting antivirals for hepatitis C virus-infected patients with hepatocellular carcinoma
449 Immunotherapy for advanced hepatocellular carcinoma: From clinical trials to real-world data and future advances
450 Up to seven criteria in selection of systemic therapy for hepatocellular carcinoma
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA